SOLA Bio Japan KG, a wholly owned subsidiary based inTokyo, Japan was established to lead the global clinicaldevelopment of SOL-257, SOLA’s lead gene therapycandidate for ALS.本部：〒103-0023東京都中央区日本橋本町2丁目3番11号
